PMC:7534795 / 5241-5445 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T2300","span":{"begin":135,"end":143},"obj":"Body_part"}],"attributes":[{"id":"A69341","pred":"fma_id","subj":"T2300","obj":"http://purl.org/sig/ont/fma/fma84050"}],"text":"-6 • Tocilizumab (anti-IL-6 receptor), siltuximab (anti-IL-6), and sirukumab (anti-IL-6) are proposed as possible treatments to manage cytokine storm and elevated IL-6 levels (Akhmerov \u0026 Marban, 2020; Hen"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T40","span":{"begin":23,"end":25},"obj":"Chemical"},{"id":"T42","span":{"begin":56,"end":58},"obj":"Chemical"},{"id":"T44","span":{"begin":83,"end":85},"obj":"Chemical"},{"id":"T46","span":{"begin":163,"end":165},"obj":"Chemical"}],"attributes":[{"id":"A40","pred":"chebi_id","subj":"T40","obj":"http://purl.obolibrary.org/obo/CHEBI_63895"},{"id":"A41","pred":"chebi_id","subj":"T40","obj":"http://purl.obolibrary.org/obo/CHEBI_74072"},{"id":"A42","pred":"chebi_id","subj":"T42","obj":"http://purl.obolibrary.org/obo/CHEBI_63895"},{"id":"A43","pred":"chebi_id","subj":"T42","obj":"http://purl.obolibrary.org/obo/CHEBI_74072"},{"id":"A44","pred":"chebi_id","subj":"T44","obj":"http://purl.obolibrary.org/obo/CHEBI_63895"},{"id":"A45","pred":"chebi_id","subj":"T44","obj":"http://purl.obolibrary.org/obo/CHEBI_74072"},{"id":"A46","pred":"chebi_id","subj":"T46","obj":"http://purl.obolibrary.org/obo/CHEBI_63895"},{"id":"A47","pred":"chebi_id","subj":"T46","obj":"http://purl.obolibrary.org/obo/CHEBI_74072"}],"text":"-6 • Tocilizumab (anti-IL-6 receptor), siltuximab (anti-IL-6), and sirukumab (anti-IL-6) are proposed as possible treatments to manage cytokine storm and elevated IL-6 levels (Akhmerov \u0026 Marban, 2020; Hen"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T22","span":{"begin":135,"end":149},"obj":"Phenotype"}],"attributes":[{"id":"A22","pred":"hp_id","subj":"T22","obj":"http://purl.obolibrary.org/obo/HP_0033041"}],"text":"-6 • Tocilizumab (anti-IL-6 receptor), siltuximab (anti-IL-6), and sirukumab (anti-IL-6) are proposed as possible treatments to manage cytokine storm and elevated IL-6 levels (Akhmerov \u0026 Marban, 2020; Hen"}

{"project":"2_test","denotations":[{"id":"33031856-32252591-84038802","span":{"begin":195,"end":199},"obj":"32252591"}],"text":"-6 • Tocilizumab (anti-IL-6 receptor), siltuximab (anti-IL-6), and sirukumab (anti-IL-6) are proposed as possible treatments to manage cytokine storm and elevated IL-6 levels (Akhmerov \u0026 Marban, 2020; Hen"}

{"project":"LitCovid-PubTator","denotations":[{"id":"157","span":{"begin":56,"end":60},"obj":"Gene"},{"id":"158","span":{"begin":83,"end":87},"obj":"Gene"},{"id":"159","span":{"begin":163,"end":167},"obj":"Gene"}],"attributes":[{"id":"A157","pred":"tao:has_database_id","subj":"157","obj":"Gene:3569"},{"id":"A158","pred":"tao:has_database_id","subj":"158","obj":"Gene:3569"},{"id":"A159","pred":"tao:has_database_id","subj":"159","obj":"Gene:3569"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"-6 • Tocilizumab (anti-IL-6 receptor), siltuximab (anti-IL-6), and sirukumab (anti-IL-6) are proposed as possible treatments to manage cytokine storm and elevated IL-6 levels (Akhmerov \u0026 Marban, 2020; Hen"}